• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Home | Biochemicals | Cancer Biology | Anticancer | Tyrosine Kinase Inhibitors | JAK

JAK

Product ID
Name
Description
Purity
  • P337538

    (-)-Pinostrobin

    Neuroprotective flavonoid

    ≥99%
  • H189921

    1,2,3,4,5,6-Hexabromocyclohexane

    ≥98%
  • A9812

    AZD-1480

    JAK1/2 inhibitor.

    ≥99%
  • B022691

    Baricitinib

    Selective and reversible JAK inhibitor.

    ≥98%
  • B030966

    BAY 11-7082

    inhibits inflammatory signaling

    ≥98%
  • B5000

    BMS-911543

    JAK2 inhibitor.

    ≥99%
  • C822706

    Curvularin

    Macrocyclic lactone.

    ≥98%
  • C9876

    CYT-387

    JAK2 inhibitor.

    ≥98%
  • D364086

    Decernotinib

    JAK3 inhibitor.

    ≥99%
  • G4662

    GLPG-0634

    JAK1 inhibitor.

    ≥98%
  • I5210

    INCB018424

    JAK1/2 inhibitor.

    ≥98%
  • J0240

    JAK2 Inhibitor V

    JAK2 inhibitor.

    ≥98%
  • L1817

    Leflunomide

    AhR agonist, dihydroorotate dehydrogenase inhib...

    ≥98%
  • L1875

    Lestaurtinib

    PRK1, JAK, FLT3 inhibitor.

    ≥98%
  • S2957

    Shogaol

    Phenol found in Zingiber; PPARγ agonist, 5-HT3...

    ≥98%
  • T2404

    TG101348

    JAK2 inhibitor.

    ≥98%
  • T5720

    Tofacitinib Citrate

    JAK1/2/3 inhibitor.

    ≥99%
  • T9969

    Tyrphostin AG490

    JAK2 inhibitor, potential EGFR inhibitor.

    ≥98%
  • W2933

    WHI-P131

    JAK3 and EGFR inhibitor.

    ≥99%

Showing all 19 results

sidebar

Store Sidebar

Product Categories

  • Biochemicals (3006)
    • Cancer Biology (1409)
      • Anti-angiogenic (184)
      • Anti-metastatic (85)
      • Anticancer (1162)
        • Anti-mitotics (64)
        • Compounds targeting DNA synthesis and repair (103)
        • DNA Crosslinking and Alkylating Agents (31)
        • Epigenetic Modifiers (49)
        • Hormone Receptor Modulators (37)
        • Inhibitors of other enzymes (76)
        • Nucleoside and Nucleotide Analogs (26)
        • Serine/Threonine Kinase Inhibitors (211)
        • Transcription Factor Modifiers (94)
        • Tyrosine Kinase Inhibitors (144)
          • Abl (15)
          • ALK (19)
          • Axl (5)
          • BTK (4)
          • c-kit (15)
          • c-met (12)
          • EGFR (35)
          • ephR (2)
          • FAK (5)
          • FGFR (9)
          • FLT (11)
          • FYN (2)
          • IGF-1R (8)
          • JAK (19)
          • LCK (3)
          • PDGFR (25)
          • RET (10)
          • Ron (5)
          • ROS1 (5)
          • src (12)
          • TIE (4)
          • TRK (3)
          • VEGFR (26)
      • Antioxidant (358)
      • Carcinogens and Mutagens (39)
      • Chemopreventive (159)
    • Cardiovascular (464)
    • Endocrine Signaling and Immunology (1042)
    • Metabolic and GI Pathology (371)
    • Microbiology (661)
    • Natural Products (723)
    • Neuroscience (791)
    • Peptides (574)
    • Pharmaceutical Impurities and Derivatives (62)
    • Stem Cell Modulators (21)
  • New Products (70)
  • Other Products (66)
  • Uncategorized (13)

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2022 LKT Laboratories, All Rights Reserved - Products for research use only